Monday, 31 August 2026European Markets

HAMMERSON PLC Stock Over 23% Down In The Last 10 Sessions

Loading stream...

(VIANEWS) - Shares of HAMMERSON PLC (ISEQ All Share: HMSO.IR) slid by a staggering 23.88% in 10 sessions from €0.29 to €0.22 at 08:24 EST on Friday, after five sequential sessions in a row of losses. ISEQ All Share is rising 1.03% to €8,126.09, following the last session's upward trend.

HAMMERSON PLC's last close was €0.22, 29.03% below its 52-week high of €0.31.

About HAMMERSON PLC

At Hammerson, we create vibrant, continually evolving spaces, in and around major cities, where people and brands want to be. We seek to deliver value for all our stakeholders and to create a positive and sustainable impact for generations to come. We own and operate high-quality flagship destinations and have investments in premium outlets in selected European countries and have a City Quarters strategy to evolve our portfolio beyond retail.

Earnings Per Share

As for profitability, HAMMERSON PLC has a trailing twelve months EPS of €-76.9.

The company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is negative -6.16%.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Oct 6, 2022, the estimated forward annual dividend yield is 1.38%.

Moving Average

HAMMERSON PLC's worth is way under its 50-day moving average of €0.28 and below its 200-day moving average of €0.23.

More news about HAMMERSON PLC (HMSO.IR).

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Hawkish Fed Signals at Jackson Hole Pressure Rate-Sensitive Assets
Kevin Warsh's hawkish inflation remarks at Jackson Hole, alongside a steady drumbeat of Federal Reserve testimony from Powell, Barr, Bowman and other officials on supervision, regulation and monetary policy, signal continued vigilance against inflation rather than an imminent easing cycle. Rate-sensitive and precious-metals-linked names such as SSR Mining sold off the same day, consistent with markets repricing for a firmer-for-longer policy stance.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,979
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,979 facts checked against source5,261 source documents archived
Query this data → isubstrate.com